Research Analysts’ New Coverage for January 6th (BBIO, CNCK, DRH, DUOL, EU, HLF, INTU, PH, PNFP, WCN)

Research Analysts’ new coverage for Tuesday, January 6th:

Morgan Stanley initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO). The firm issued an overweight rating and a $96.00 price target on the stock.

Compass Point initiated coverage on shares of Coincheck Group (NASDAQ:CNCK). Compass Point issued a buy rating and a $5.00 price target on the stock.

Barclays PLC began coverage on shares of DiamondRock Hospitality (NYSE:DRH). Barclays PLC issued an equal weight rating and a $10.00 price target on the stock.

Truist Financial Corporation assumed coverage on shares of Duolingo (NASDAQ:DUOL). They issued a buy rating and a $245.00 price target on the stock.

Northland Securities began coverage on shares of enCore Energy (NASDAQ:EU). The firm issued an outperform rating and a $3.50 target price on the stock.

Maxim Group assumed coverage on shares of Herbalife (NYSE:HLF). They issued a buy rating and a $20.00 price target on the stock.

Truist Financial Corporation assumed coverage on shares of Intuit (NASDAQ:INTU). The firm issued a buy rating and a $739.00 target price on the stock.

JPMorgan Chase & Co. assumed coverage on shares of Parker-Hannifin (NYSE:PH). They issued an overweight rating and a $1,050.00 target price on the stock.

Evercore ISI assumed coverage on shares of Pinnacle Financial Partners (NASDAQ:PNFP). Evercore ISI issued an outperform rating and a $115.00 target price on the stock.

BNP Paribas Exane began coverage on shares of Waste Connections (NYSE:WCN). They issued an outperform rating on the stock.

Citizens Jmp began coverage on shares of LifeGoal Wealth Builder ETF (NYSEARCA:WLTH). They issued a market outperform rating and a $20.00 price target on the stock.

Wells Fargo & Company started coverage on shares of LifeGoal Wealth Builder ETF (NYSEARCA:WLTH). Wells Fargo & Company issued an overweight rating and a $16.50 price target on the stock.

KeyCorp assumed coverage on shares of LifeGoal Wealth Builder ETF (NYSEARCA:WLTH). They issued a sector weight rating on the stock.

Royal Bank Of Canada started coverage on shares of LifeGoal Wealth Builder ETF (NYSEARCA:WLTH). The firm issued an outperform rating and a $17.00 price target on the stock.

JPMorgan Chase & Co. began coverage on shares of LifeGoal Wealth Builder ETF (NYSEARCA:WLTH). JPMorgan Chase & Co. issued an overweight rating and a $16.00 target price on the stock.

Keefe, Bruyette & Woods started coverage on shares of LifeGoal Wealth Builder ETF (NYSEARCA:WLTH). The firm issued an outperform rating and a $16.50 target price on the stock.

The Goldman Sachs Group, Inc. assumed coverage on shares of LifeGoal Wealth Builder ETF (NYSEARCA:WLTH). They issued a neutral rating and a $14.50 target price on the stock.

Receive News & Ratings for BridgeBio Pharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BridgeBio Pharma Inc and related companies with MarketBeat.com's FREE daily email newsletter.